Ambit Biosciences
Ambit Biosciences Corporation is a biopharmaceutical company based in San Diego, CA, dedicated to the discovery, development, and commercialization of innovative drugs targeting unmet medical needs in oncology, autoimmune, and inflammatory diseases. The company focuses on inhibiting kinases that drive these diseases, with a robust pipeline that includes internally discovered programs aimed at validated kinase targets.
The company's lead drug candidate, quizartinib, is a potent and selective FLT3 kinase inhibitor administered once daily, currently in development for treating acute myeloid leukemia (AML). Ambit leverages its kinase expertise to optimize and develop a sustainable pipeline of small molecule kinase inhibitors, positioning itself as a key partner in the field.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.